2026. Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients. Pakistan Journal of Medical & Cardiological Review. 5, 1 (Jan. 2026), 163–174. DOI:https://doi.org/10.5281/zenodo.18345788.